

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of chemokine secretion (GO:0090197) | 5.34171673 |
| 2 | ribosomal small subunit biogenesis (GO:0042274) | 5.01317146 |
| 3 | regulation of chemokine secretion (GO:0090196) | 4.55711571 |
| 4 | oligosaccharide catabolic process (GO:0009313) | 4.31755206 |
| 5 | viral transcription (GO:0019083) | 4.03619355 |
| 6 | interferon-gamma secretion (GO:0072643) | 4.01837880 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.97628905 |
| 8 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.84167687 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.78416777 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.78416777 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 3.78416777 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 3.78416777 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 3.78416777 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.78416777 |
| 15 | response to protozoan (GO:0001562) | 3.77567939 |
| 16 | T-helper 1 type immune response (GO:0042088) | 3.77347102 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.76442491 |
| 18 | translational termination (GO:0006415) | 3.75390054 |
| 19 | NIK/NF-kappaB signaling (GO:0038061) | 3.54790711 |
| 20 | response to host immune response (GO:0052572) | 3.45037333 |
| 21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.45037333 |
| 22 | response to type I interferon (GO:0034340) | 3.37492845 |
| 23 | response to peptidoglycan (GO:0032494) | 3.33847671 |
| 24 | amino sugar catabolic process (GO:0046348) | 3.31556355 |
| 25 | response to host (GO:0075136) | 3.31333995 |
| 26 | response to host defenses (GO:0052200) | 3.31333995 |
| 27 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.31333995 |
| 28 | negative regulation of T cell mediated immunity (GO:0002710) | 3.27307105 |
| 29 | type I interferon signaling pathway (GO:0060337) | 3.27135694 |
| 30 | cellular response to type I interferon (GO:0071357) | 3.27135694 |
| 31 | tolerance induction (GO:0002507) | 3.26277326 |
| 32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.20061761 |
| 33 | negative regulation of cell killing (GO:0031342) | 3.20061761 |
| 34 | viral life cycle (GO:0019058) | 3.19813048 |
| 35 | translational elongation (GO:0006414) | 3.19312202 |
| 36 | regulation of T-helper 1 type immune response (GO:0002825) | 3.14151565 |
| 37 | defense response to protozoan (GO:0042832) | 3.13937434 |
| 38 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.13773487 |
| 39 | negative regulation of interleukin-12 production (GO:0032695) | 3.13647641 |
| 40 | cotranslational protein targeting to membrane (GO:0006613) | 3.11523470 |
| 41 | macrophage activation involved in immune response (GO:0002281) | 3.11443452 |
| 42 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.11335066 |
| 43 | ncRNA 3-end processing (GO:0043628) | 3.11252499 |
| 44 | negative regulation of interleukin-6 production (GO:0032715) | 3.10123299 |
| 45 | protein targeting to ER (GO:0045047) | 3.09355018 |
| 46 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.09348393 |
| 47 | leukocyte aggregation (GO:0070486) | 3.09323637 |
| 48 | protein-cofactor linkage (GO:0018065) | 3.08345026 |
| 49 | regulation of B cell differentiation (GO:0045577) | 3.06939676 |
| 50 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.05951129 |
| 51 | negative regulation of macrophage differentiation (GO:0045650) | 3.04624104 |
| 52 | cellular response to exogenous dsRNA (GO:0071360) | 3.00421680 |
| 53 | response to interferon-alpha (GO:0035455) | 2.96785162 |
| 54 | response to interferon-beta (GO:0035456) | 2.95080369 |
| 55 | respiratory burst (GO:0045730) | 2.94526939 |
| 56 | lymphocyte chemotaxis (GO:0048247) | 2.93480511 |
| 57 | negative regulation of viral genome replication (GO:0045071) | 2.92199976 |
| 58 | immunoglobulin mediated immune response (GO:0016064) | 2.90114438 |
| 59 | protein localization to endoplasmic reticulum (GO:0070972) | 2.89647965 |
| 60 | neutrophil activation involved in immune response (GO:0002283) | 2.88244469 |
| 61 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.87073403 |
| 62 | cellular protein complex disassembly (GO:0043624) | 2.86520073 |
| 63 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.82177420 |
| 64 | regulation of mast cell degranulation (GO:0043304) | 2.81903825 |
| 65 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.77743107 |
| 66 | regulation of gamma-delta T cell activation (GO:0046643) | 2.74126479 |
| 67 | negative regulation of adaptive immune response (GO:0002820) | 2.73882383 |
| 68 | detection of other organism (GO:0098543) | 2.72732851 |
| 69 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.72524958 |
| 70 | cellular response to virus (GO:0098586) | 2.72432588 |
| 71 | granulocyte activation (GO:0036230) | 2.72209499 |
| 72 | negative regulation of interferon-gamma production (GO:0032689) | 2.69916443 |
| 73 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.69862367 |
| 74 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.67971705 |
| 75 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.67779238 |
| 76 | myeloid cell activation involved in immune response (GO:0002275) | 2.65966156 |
| 77 | regulation of interleukin-5 production (GO:0032674) | 2.65889761 |
| 78 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.64901806 |
| 79 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.62391123 |
| 80 | positive thymic T cell selection (GO:0045059) | 2.61694630 |
| 81 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.61477631 |
| 82 | regulation of defense response to virus by host (GO:0050691) | 2.61320245 |
| 83 | leukocyte degranulation (GO:0043299) | 2.60956879 |
| 84 | detection of bacterium (GO:0016045) | 2.60897828 |
| 85 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.60703123 |
| 86 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.60673854 |
| 87 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.60672983 |
| 88 | macrophage activation (GO:0042116) | 2.57086502 |
| 89 | positive regulation of type 2 immune response (GO:0002830) | 2.55209841 |
| 90 | N-acetylneuraminate metabolic process (GO:0006054) | 2.54713551 |
| 91 | positive regulation of defense response to virus by host (GO:0002230) | 2.54608523 |
| 92 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.53936127 |
| 93 | regulation of mast cell activation (GO:0033003) | 2.52694049 |
| 94 | DNA deamination (GO:0045006) | 2.52614464 |
| 95 | cellular response to interleukin-4 (GO:0071353) | 2.51024511 |
| 96 | positive regulation of macrophage activation (GO:0043032) | 2.50727796 |
| 97 | GDP-mannose metabolic process (GO:0019673) | 2.50673207 |
| 98 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.50175256 |
| 99 | positive regulation of B cell differentiation (GO:0045579) | 2.49435372 |
| 100 | response to muramyl dipeptide (GO:0032495) | 2.49407750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.14434644 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.72363171 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.49854391 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.38257332 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.78203597 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.42883150 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.37118257 |
| 8 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.28701952 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.24205445 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.23515478 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.19765227 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.13107092 |
| 13 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.12336080 |
| 14 | MAF_26560356_Chip-Seq_TH2_Human | 2.11127233 |
| 15 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.10543421 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03525887 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.00560240 |
| 18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.99876517 |
| 19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.98782559 |
| 20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98278170 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 1.96022149 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.93552392 |
| 23 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.90037174 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.87225862 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86664879 |
| 26 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.83633296 |
| 27 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.82690903 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.81183068 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80316940 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.79833099 |
| 31 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.79145592 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78628296 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75773058 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.75372779 |
| 35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.75151814 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.75096980 |
| 37 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.74719024 |
| 38 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.74571218 |
| 39 | MYC_22102868_ChIP-Seq_BL_Human | 1.71579809 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.66698691 |
| 41 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59909480 |
| 42 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.59369330 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54927941 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52207637 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50497264 |
| 46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.49801863 |
| 47 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.49451683 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48229206 |
| 49 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.47722124 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.47336015 |
| 51 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.46762516 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.45174514 |
| 53 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44006132 |
| 54 | MYB_26560356_Chip-Seq_TH1_Human | 1.43566193 |
| 55 | MYB_26560356_Chip-Seq_TH2_Human | 1.42643260 |
| 56 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.41377450 |
| 57 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.40475903 |
| 58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39963243 |
| 59 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.37079505 |
| 60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35822690 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.35679123 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33308630 |
| 63 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.28198362 |
| 64 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.27519436 |
| 65 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.27255810 |
| 66 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.26155594 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25898237 |
| 68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.24832525 |
| 69 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.24504123 |
| 70 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.23785872 |
| 71 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22229395 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.21650644 |
| 73 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20685942 |
| 74 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.20337975 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 1.20129985 |
| 76 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20053941 |
| 77 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20009087 |
| 78 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.19953950 |
| 79 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.18947748 |
| 80 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.18908385 |
| 81 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.18697744 |
| 82 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.16906527 |
| 83 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16810288 |
| 84 | P68_20966046_ChIP-Seq_HELA_Human | 1.15981385 |
| 85 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.15034952 |
| 86 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.13856072 |
| 87 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11794800 |
| 88 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.11579512 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10836273 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10502582 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09994202 |
| 92 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.08139566 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07227143 |
| 94 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.05323879 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04327778 |
| 96 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04200780 |
| 97 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03992349 |
| 98 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.03814486 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03623566 |
| 100 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02842862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.14570079 |
| 2 | MP0003436_decreased_susceptibility_to | 3.44719634 |
| 3 | MP0003724_increased_susceptibility_to | 3.43672950 |
| 4 | MP0004510_myositis | 3.38595201 |
| 5 | MP0005671_abnormal_response_to | 2.89556674 |
| 6 | MP0009785_altered_susceptibility_to | 2.84597232 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.84031649 |
| 8 | MP0000685_abnormal_immune_system | 2.77380322 |
| 9 | MP0005025_abnormal_response_to | 2.70852063 |
| 10 | MP0001800_abnormal_humoral_immune | 2.64589342 |
| 11 | MP0002419_abnormal_innate_immunity | 2.57835948 |
| 12 | MP0002723_abnormal_immune_serum | 2.57514084 |
| 13 | MP0005387_immune_system_phenotype | 2.55241973 |
| 14 | MP0001790_abnormal_immune_system | 2.55241973 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.46750469 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.46460239 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.32404049 |
| 18 | MP0009278_abnormal_bone_marrow | 2.25887201 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.24418202 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.21244500 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.21087678 |
| 22 | MP0001819_abnormal_immune_cell | 2.19269633 |
| 23 | MP0001835_abnormal_antigen_presentation | 2.13062709 |
| 24 | MP0002132_abnormal_respiratory_system | 2.02670275 |
| 25 | MP0002405_respiratory_system_inflammati | 2.02125929 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.96836350 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.91958429 |
| 28 | MP0002277_abnormal_respiratory_mucosa | 1.86047999 |
| 29 | MP0005451_abnormal_body_composition | 1.83872552 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.80935120 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.79997530 |
| 32 | MP0000716_abnormal_immune_system | 1.78072274 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.75658287 |
| 34 | MP0006082_CNS_inflammation | 1.74219913 |
| 35 | MP0004947_skin_inflammation | 1.69013123 |
| 36 | MP0005310_abnormal_salivary_gland | 1.68186347 |
| 37 | MP0002398_abnormal_bone_marrow | 1.64155965 |
| 38 | MP0008260_abnormal_autophagy | 1.62946845 |
| 39 | MP0008469_abnormal_protein_level | 1.49931987 |
| 40 | MP0002429_abnormal_blood_cell | 1.46862380 |
| 41 | MP0004381_abnormal_hair_follicle | 1.43144905 |
| 42 | MP0008961_abnormal_basal_metabolism | 1.39546428 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.36484201 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.34961910 |
| 45 | MP0001853_heart_inflammation | 1.34703579 |
| 46 | MP0002722_abnormal_immune_system | 1.34431209 |
| 47 | MP0009764_decreased_sensitivity_to | 1.32487238 |
| 48 | MP0001873_stomach_inflammation | 1.31825575 |
| 49 | MP0000858_altered_metastatic_potential | 1.30475799 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.28864093 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.25786587 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.24130416 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.24130416 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.23177649 |
| 55 | MP0002653_abnormal_ependyma_morphology | 1.22701970 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.21154342 |
| 57 | MP0009765_abnormal_xenobiotic_induced | 1.17717507 |
| 58 | MP0009763_increased_sensitivity_to | 1.15112117 |
| 59 | MP0000343_altered_response_to | 1.15026073 |
| 60 | MP0005084_abnormal_gallbladder_morpholo | 1.08351179 |
| 61 | MP0003866_abnormal_defecation | 1.08276876 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.06731633 |
| 63 | MP0002396_abnormal_hematopoietic_system | 1.05467718 |
| 64 | MP0005464_abnormal_platelet_physiology | 1.04404060 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.01242584 |
| 66 | MP0001764_abnormal_homeostasis | 1.00618683 |
| 67 | MP0000703_abnormal_thymus_morphology | 0.99621038 |
| 68 | MP0001663_abnormal_digestive_system | 0.98137115 |
| 69 | MP0003315_abnormal_perineum_morphology | 0.97982200 |
| 70 | MP0003828_pulmonary_edema | 0.96121903 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 0.94270126 |
| 72 | MP0001851_eye_inflammation | 0.92622568 |
| 73 | MP0005390_skeleton_phenotype | 0.89608201 |
| 74 | MP0002009_preneoplasia | 0.89169718 |
| 75 | MP0002928_abnormal_bile_duct | 0.88221418 |
| 76 | MP0008873_increased_physiological_sensi | 0.88177503 |
| 77 | MP0005501_abnormal_skin_physiology | 0.85821091 |
| 78 | MP0009840_abnormal_foam_cell | 0.83465438 |
| 79 | MP0003136_yellow_coat_color | 0.79686117 |
| 80 | MP0005164_abnormal_response_to | 0.77640586 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 0.74832381 |
| 82 | MP0005083_abnormal_biliary_tract | 0.74758981 |
| 83 | MP0001919_abnormal_reproductive_system | 0.71278635 |
| 84 | MP0002933_joint_inflammation | 0.69365745 |
| 85 | MP0003183_abnormal_peptide_metabolism | 0.68580777 |
| 86 | MP0005166_decreased_susceptibility_to | 0.66346638 |
| 87 | MP0002877_abnormal_melanocyte_morpholog | 0.66106320 |
| 88 | MP0002796_impaired_skin_barrier | 0.65893343 |
| 89 | MP0003075_altered_response_to | 0.65585974 |
| 90 | MP0003938_abnormal_ear_development | 0.63535024 |
| 91 | MP0000372_irregular_coat_pigmentation | 0.62762230 |
| 92 | MP0005381_digestive/alimentary_phenotyp | 0.62026363 |
| 93 | MP0002019_abnormal_tumor_incidence | 0.61176010 |
| 94 | MP0004133_heterotaxia | 0.60998869 |
| 95 | MP0003279_aneurysm | 0.59830227 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.59105994 |
| 97 | MP0002139_abnormal_hepatobiliary_system | 0.59059502 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 0.58991409 |
| 99 | MP0005187_abnormal_penis_morphology | 0.58933626 |
| 100 | MP0003186_abnormal_redox_activity | 0.58146258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 4.57950636 |
| 2 | Myositis (HP:0100614) | 4.23831533 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.17883588 |
| 4 | Abnormality of macrophages (HP:0004311) | 3.97777329 |
| 5 | 3-Methylglutaconic aciduria (HP:0003535) | 3.87636147 |
| 6 | Gastrointestinal infarctions (HP:0005244) | 3.85326517 |
| 7 | Eczematoid dermatitis (HP:0000976) | 3.84044156 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 3.72153170 |
| 9 | Orchitis (HP:0100796) | 3.53162851 |
| 10 | Recurrent fungal infections (HP:0002841) | 3.47249298 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.44828585 |
| 12 | Pustule (HP:0200039) | 3.41987789 |
| 13 | Optic neuritis (HP:0100653) | 3.36063845 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 3.36063845 |
| 15 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.14193966 |
| 16 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.14193966 |
| 17 | Stomatitis (HP:0010280) | 3.07376366 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.04664211 |
| 19 | Aplastic anemia (HP:0001915) | 3.04575389 |
| 20 | Hypertensive crisis (HP:0100735) | 2.98320019 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 2.98137108 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.98137108 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.98137108 |
| 24 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.97086661 |
| 25 | Abnormal number of erythroid precursors (HP:0012131) | 2.93121098 |
| 26 | Recurrent skin infections (HP:0001581) | 2.92923015 |
| 27 | Anorexia (HP:0002039) | 2.90716659 |
| 28 | Obstructive lung disease (HP:0006536) | 2.79886417 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 2.79886417 |
| 30 | Encephalitis (HP:0002383) | 2.77974343 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 2.76921945 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.76921945 |
| 33 | Pallor (HP:0000980) | 2.73631001 |
| 34 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.71641713 |
| 35 | Nasolacrimal duct obstruction (HP:0000579) | 2.67799323 |
| 36 | Meningitis (HP:0001287) | 2.65105698 |
| 37 | Panhypogammaglobulinemia (HP:0003139) | 2.64480455 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 2.58991199 |
| 39 | Abnormality of homocysteine metabolism (HP:0010919) | 2.46947074 |
| 40 | Homocystinuria (HP:0002156) | 2.46947074 |
| 41 | Recurrent viral infections (HP:0004429) | 2.45776408 |
| 42 | Pulmonary infiltrates (HP:0002113) | 2.42824446 |
| 43 | Respiratory difficulties (HP:0002880) | 2.42560441 |
| 44 | Increased IgE level (HP:0003212) | 2.42507790 |
| 45 | Vasculitis (HP:0002633) | 2.38469261 |
| 46 | Macrocytic anemia (HP:0001972) | 2.34592215 |
| 47 | Abnormality of the parietal bone (HP:0002696) | 2.31999286 |
| 48 | Hemoptysis (HP:0002105) | 2.24699847 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.24346680 |
| 50 | Keratoconjunctivitis sicca (HP:0001097) | 2.23500581 |
| 51 | Abnormality of T cells (HP:0002843) | 2.23422156 |
| 52 | Increased serum ferritin (HP:0003281) | 2.20034878 |
| 53 | Hepatosplenomegaly (HP:0001433) | 2.18814475 |
| 54 | Increased intramyocellular lipid droplets (HP:0012240) | 2.18690865 |
| 55 | Increased muscle lipid content (HP:0009058) | 2.17512396 |
| 56 | Urticaria (HP:0001025) | 2.15134814 |
| 57 | Vacuolated lymphocytes (HP:0001922) | 2.14308331 |
| 58 | Tetany (HP:0001281) | 2.13028083 |
| 59 | Cheilitis (HP:0100825) | 2.12388669 |
| 60 | Alopecia of scalp (HP:0002293) | 2.11463812 |
| 61 | Hypochromic anemia (HP:0001931) | 2.11400543 |
| 62 | Global brain atrophy (HP:0002283) | 2.10007887 |
| 63 | Dysostosis multiplex (HP:0000943) | 2.09638415 |
| 64 | Keratitis (HP:0000491) | 2.08209097 |
| 65 | Conical tooth (HP:0000698) | 2.05840903 |
| 66 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.03479992 |
| 67 | Concave nail (HP:0001598) | 2.03082443 |
| 68 | Lymphopenia (HP:0001888) | 2.01655852 |
| 69 | Stomach cancer (HP:0012126) | 1.98641760 |
| 70 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.97533705 |
| 71 | Methylmalonic aciduria (HP:0012120) | 1.91903522 |
| 72 | Episodic fever (HP:0001954) | 1.91765430 |
| 73 | Premature graying of hair (HP:0002216) | 1.91279231 |
| 74 | Keratoconjunctivitis (HP:0001096) | 1.90587247 |
| 75 | Gastrointestinal stroma tumor (HP:0100723) | 1.89326814 |
| 76 | Interstitial pulmonary disease (HP:0006530) | 1.88659044 |
| 77 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.86640255 |
| 78 | Gingivitis (HP:0000230) | 1.85762097 |
| 79 | Oral leukoplakia (HP:0002745) | 1.85749680 |
| 80 | Chronic otitis media (HP:0000389) | 1.84640433 |
| 81 | Cellulitis (HP:0100658) | 1.84352357 |
| 82 | Renal Fanconi syndrome (HP:0001994) | 1.81693864 |
| 83 | Mitochondrial inheritance (HP:0001427) | 1.81212741 |
| 84 | Methylmalonic acidemia (HP:0002912) | 1.79608132 |
| 85 | Type I transferrin isoform profile (HP:0003642) | 1.78164272 |
| 86 | Abnormality of the pericardium (HP:0001697) | 1.78003737 |
| 87 | Acute necrotizing encephalopathy (HP:0006965) | 1.77795611 |
| 88 | Abnormal protein glycosylation (HP:0012346) | 1.77411258 |
| 89 | Abnormal glycosylation (HP:0012345) | 1.77411258 |
| 90 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.77411258 |
| 91 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.77411258 |
| 92 | Reticulocytopenia (HP:0001896) | 1.74826423 |
| 93 | Exertional dyspnea (HP:0002875) | 1.73162964 |
| 94 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.72836426 |
| 95 | Neuroendocrine neoplasm (HP:0100634) | 1.71990784 |
| 96 | Agammaglobulinemia (HP:0004432) | 1.71569064 |
| 97 | Chronic sinusitis (HP:0011109) | 1.69034193 |
| 98 | Colitis (HP:0002583) | 1.68349596 |
| 99 | Increased hepatocellular lipid droplets (HP:0006565) | 1.67491234 |
| 100 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.66962141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 6.88611402 |
| 2 | TESK2 | 3.06291064 |
| 3 | TAOK3 | 2.87097862 |
| 4 | IRAK4 | 2.73839145 |
| 5 | TAOK1 | 2.59839568 |
| 6 | MAP2K3 | 2.47987615 |
| 7 | ERN1 | 2.47575664 |
| 8 | MAP4K1 | 2.47107418 |
| 9 | BLK | 2.27546073 |
| 10 | STK16 | 2.16317963 |
| 11 | RIPK4 | 2.04278166 |
| 12 | IKBKE | 1.93293060 |
| 13 | GRK6 | 1.91550844 |
| 14 | IKBKB | 1.91134694 |
| 15 | MAPK15 | 1.76807922 |
| 16 | PRKD2 | 1.76441013 |
| 17 | PIM2 | 1.74371526 |
| 18 | MAP3K11 | 1.70448489 |
| 19 | TBK1 | 1.68056497 |
| 20 | CDK12 | 1.62544031 |
| 21 | CHUK | 1.62213648 |
| 22 | MAP3K3 | 1.61802250 |
| 23 | CLK1 | 1.60808356 |
| 24 | ABL2 | 1.59237596 |
| 25 | CSK | 1.58101060 |
| 26 | IRAK3 | 1.54549086 |
| 27 | TAOK2 | 1.53697587 |
| 28 | MAP3K14 | 1.48923164 |
| 29 | MATK | 1.29142625 |
| 30 | ARAF | 1.27912826 |
| 31 | SIK2 | 1.23264913 |
| 32 | NME2 | 1.22126977 |
| 33 | TYK2 | 1.14886382 |
| 34 | TXK | 1.09825027 |
| 35 | EPHA3 | 1.08963737 |
| 36 | SIK1 | 1.08489524 |
| 37 | BTK | 1.06424545 |
| 38 | ZAP70 | 1.06255882 |
| 39 | TESK1 | 1.03316884 |
| 40 | FES | 1.02294076 |
| 41 | PRPF4B | 0.95612969 |
| 42 | HCK | 0.95428370 |
| 43 | SYK | 0.95192811 |
| 44 | MAP3K13 | 0.91178793 |
| 45 | EPHB1 | 0.89698680 |
| 46 | RPS6KA6 | 0.88571787 |
| 47 | MAP3K1 | 0.87757031 |
| 48 | RPS6KC1 | 0.86442077 |
| 49 | RPS6KL1 | 0.86442077 |
| 50 | LYN | 0.85072435 |
| 51 | PDPK1 | 0.84813046 |
| 52 | PIM1 | 0.83248186 |
| 53 | GRK7 | 0.83113021 |
| 54 | NEK2 | 0.81724163 |
| 55 | EIF2AK1 | 0.79877478 |
| 56 | MAP2K6 | 0.77990464 |
| 57 | IRAK1 | 0.73339936 |
| 58 | TNK2 | 0.73128453 |
| 59 | JAK3 | 0.72831927 |
| 60 | PAK4 | 0.69270386 |
| 61 | TRIB3 | 0.68540136 |
| 62 | MARK2 | 0.67872527 |
| 63 | CSF1R | 0.67584659 |
| 64 | LCK | 0.64183896 |
| 65 | RPS6KA5 | 0.63133676 |
| 66 | SRPK1 | 0.62647679 |
| 67 | PRKCQ | 0.58932338 |
| 68 | MAPKAPK2 | 0.58359495 |
| 69 | MARK3 | 0.56155842 |
| 70 | CDC42BPA | 0.53190318 |
| 71 | KIT | 0.51904104 |
| 72 | PDK1 | 0.50557446 |
| 73 | PRKD1 | 0.50303627 |
| 74 | RPS6KA1 | 0.49947412 |
| 75 | JAK2 | 0.48682180 |
| 76 | ITK | 0.45537187 |
| 77 | PRKCI | 0.45227816 |
| 78 | RAF1 | 0.45066978 |
| 79 | JAK1 | 0.42827385 |
| 80 | HIPK2 | 0.41689589 |
| 81 | STK10 | 0.40981010 |
| 82 | BUB1 | 0.39844524 |
| 83 | MELK | 0.39158911 |
| 84 | IRAK2 | 0.38477677 |
| 85 | ADRBK2 | 0.36981974 |
| 86 | SIK3 | 0.36891652 |
| 87 | PASK | 0.36271753 |
| 88 | MAPK11 | 0.35905038 |
| 89 | FGR | 0.35298082 |
| 90 | ABL1 | 0.34798213 |
| 91 | CDK4 | 0.34747026 |
| 92 | CDK9 | 0.34575786 |
| 93 | CDK3 | 0.33880763 |
| 94 | MAPK3 | 0.31717570 |
| 95 | MAPK12 | 0.30899085 |
| 96 | EPHA2 | 0.30765353 |
| 97 | MOS | 0.30663053 |
| 98 | ADRBK1 | 0.27932415 |
| 99 | RPS6KA2 | 0.27368561 |
| 100 | BCKDK | 0.24396991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.77965369 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.55859390 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.41122882 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.33991392 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.17290672 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.15639310 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.08138583 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.06100230 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.04910833 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.03517182 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.98917905 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.97371951 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.95253913 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.88208041 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.84531453 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.78319932 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.69392746 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.62456041 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61612345 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.58246705 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.52951256 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.47882763 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.45840177 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.45356436 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45261307 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.42961403 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.41862141 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41299889 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.38919934 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.38608537 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.36889156 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.36559749 |
| 33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.36185736 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35564598 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.32632275 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30760793 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.28555256 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.26254599 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25494372 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.23381698 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.20689094 |
| 42 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.20440501 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.19608862 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17316822 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16778721 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.14437970 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09118669 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.09068388 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 1.07662448 |
| 50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07212019 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.04879716 |
| 52 | Asthma_Homo sapiens_hsa05310 | 1.04090944 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 1.01641710 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 1.01137624 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99278690 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 0.93818112 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.91922991 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87378374 |
| 59 | Huntingtons disease_Homo sapiens_hsa05016 | 0.87007690 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86856667 |
| 61 | Alzheimers disease_Homo sapiens_hsa05010 | 0.82319388 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82127774 |
| 63 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81427269 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.80284141 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78471607 |
| 66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.78415029 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70904960 |
| 68 | Homologous recombination_Homo sapiens_hsa03440 | 0.70264301 |
| 69 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.69793000 |
| 70 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67884142 |
| 71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67329368 |
| 72 | Proteasome_Homo sapiens_hsa03050 | 0.67256175 |
| 73 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.65930803 |
| 74 | Spliceosome_Homo sapiens_hsa03040 | 0.63866053 |
| 75 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63849238 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61520048 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60759694 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.58976660 |
| 79 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.57387240 |
| 80 | Protein export_Homo sapiens_hsa03060 | 0.56209592 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56186710 |
| 82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53989308 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51696736 |
| 84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48623571 |
| 85 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46156211 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44974137 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43880456 |
| 88 | Basal transcription factors_Homo sapiens_hsa03022 | 0.41953479 |
| 89 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.41594623 |
| 90 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.40912081 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39251147 |
| 92 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.38479772 |
| 93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36552917 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.36106740 |
| 95 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35971601 |
| 96 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.35618520 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.34328541 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33829643 |
| 99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32091927 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.31014759 |

